Laboratoires Thea
Quick facts
Marketed products
- Lumigan 0.01%
- Lumigan 0.03% Unit Dose
- NAABAK eyedrops · Ophthalmology
Phase 3 pipeline
- Mydriatics · Other
- Prostaglandin · Other
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Laboratoires Thea
What are Laboratoires Thea's marketed drugs?
Top marketed products include Lumigan 0.01%, Lumigan 0.03% Unit Dose, NAABAK eyedrops.
What is Laboratoires Thea's pipeline?
Laboratoires Thea has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Mydriatics, Prostaglandin.
Related
- Lumigan 0.01%
- Lumigan 0.03% Unit Dose
- NAABAK eyedrops · Ophthalmology
- Sector hub: All tracked pharma companies